000 | 01768 a2200457 4500 | ||
---|---|---|---|
005 | 20250517222509.0 | ||
264 | 0 | _c20181015 | |
008 | 201810s 0 0 eng d | ||
022 | _a1878-3627 | ||
024 | 7 |
_a10.3233/RNN-170808 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Rong | |
245 | 0 | 0 |
_aPhenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. _h[electronic resource] |
260 |
_bRestorative neurology and neuroscience _c2018 |
||
300 |
_a469-483 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiogenic Amines _xmetabolism |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aLocomotion _xdrug effects |
650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
650 | 0 | 4 |
_aNeural Cell Adhesion Molecule L1 _xmetabolism |
650 | 0 | 4 |
_aPhenelzine _xtherapeutic use |
650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Injuries _xdrug therapy |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSahu, Sudhanshu | |
700 | 1 | _aSchachner, Melitta | |
773 | 0 |
_tRestorative neurology and neuroscience _gvol. 36 _gno. 4 _gp. 469-483 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3233/RNN-170808 _zAvailable from publisher's website |
999 |
_c28517023 _d28517023 |